GlassScriptPhysician profile
Myron I Wolf
NPI 1063596674
$3,757.18
in general payments reported to CMS, 2019-2025
23 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $768 · 2020: $55.50 · 2021: $2,256 · 2022: $89.26 · 2023: $171 · 2024: $189 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $588.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,317.68 | 2021-2024 | |
| Stryker Corporation | $629.12 | 2019-2025 | Ortholoc 2 Lapifuse, Prostep Mica, Bioskin |
| Crossroads Extremity Systems, LLC | $108.11 | 2019 | |
| Kerecis Limited | $103.52 | 2019-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $83.82 | 2019-2022 | |
| Paragon 28, INC. | $79.95 | 2022-2025 | Bun-Yo-Matic |
| Osteocentric Technologies, INC. | $41.48 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Melinta Therapeutics, LLC | $39.77 | 2019-2022 | |
| Misonix INC | $38.51 | 2019 | |
| Fusion Orthopedics USA, LLC | $38.13 | 2024 | |
| Polynovo North America LLC | $34.76 | 2023-2025 | Novosorb Btm |
| Organogenesis INC. | $30.58 | 2023 | Puraply |
| Axogen | $28.35 | 2020 | |
| Nevro Corp. | $26.93 | 2021-2022 | |
| Osteomed LLC | $25.23 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $24.32 | 2019 | |
| Horizon Therapeutics Plc | $21.03 | 2019 | |
| Esperion Therapeutics, INC. | $16.16 | 2024 | Nexletol |
| Alfasigma USA, INC. | $15.89 | 2021 | |
| Amgen INC. | $15.07 | 2024 | Evenity, Prolia |
| Acell, INC. | $14.50 | 2020 | |
| Fidia Pharma USA INC. | $12.51 | 2019 | |
| Bioventus LLC | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Myron Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.